MyChesCo on MSN

Johnson & Johnson Reports Positive Phase 2b Results for Oral Ulcerative Colitis Therapy

SPRING HOUSE, PA — Johnson & Johnson (NYSE: JNJ) announced new data from its Phase 2b ANTHEM-UC clinical trial evaluating icotrokinra, an investigational oral therapy for adults with moderately to ...
AZoLifeSciences on MSN

Invisible Invaders: What Toxicology Reveals About Micro- and Nanoplastics

Micro- and nanoplastics are emerging threats to human health, with complex exposure pathways and toxicological effects that ...